NCT00782548View on ClinicalTrials.gov

Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Healthy
Interventions
DRUG

KADIAN (morphine sulfate sustained-release) capsules

Capsules, 30 mg

DRUG

Avinza (morphine sulfate sustained-release) capsules

Capsules, 30 mg

Trial Locations (1)

68502

MDS Pharma Services, Lincoln

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00782548 - Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults | Biotech Hunter | Biotech Hunter